The clearest difference was in the blood
Researchers found lower peripheral lymphocyte counts in people with connective-tissue disease-associated interstitial lung disease (CTD-ILD) than in healthy individuals. The lowest reported mean was 1.381 × 10^9/L in the PM/DM-ILD group. At the same time, the SSc-ILD group showed a mean T-cell proportion of 76.2% and a mean Th-cell proportion of 49.39%. Here, Th means helper T cells. The figures describe both the overall lymphocyte count and the proportions of particular T-cell groups.
The contrast with the IPF group was also clear in the reported proportions: its mean Th-cell proportion was 32.76%, below the SSc-ILD mean. That does not mean every patient in one group had a higher or lower value than every patient in another. These are group means, and the study’s result is a population-level pattern rather than a description of individual cases.
What the researchers measured
The researchers set out to characterize peripheral and pulmonary immune profiles in CTD-ILD and examine how they related to lung function, with particular emphasis on SSc-ILD. Because the work was retrospective and single-center, the findings describe an association between measured variables rather than proving that one immune-cell pattern caused a change in lung function.
The study included 217 CTD-ILD patients: 95 with PM/DM-ILD, 58 with SS-ILD, 35 with RA-ILD and 29 with SSc-ILD. It also included 100 healthy controls and 25 IPF patients. Those groups allowed the researchers to compare several CTD-ILD subtypes with people without the disease and with a separate lung-disease group.
Peripheral immune testing measured the antibodies IgA, IgG and IgM, the complement components C3 and C4, and cytokines. The researchers also quantified T-cell, B-cell and NK-cell subsets using a six-color TBNK reagent kit. In practical terms, this produced a profile of the mix of immune-cell subsets in the blood.
For the statistical comparisons, the researchers used a t-test when two groups were compared and one-way analysis of variance, followed by an LSD post hoc test, for multiple groups. They checked the data with the Shapiro-Wilk test and used Pearson or Spearman correlations depending on whether the data met the relevant assumptions. The stated cutoffs were and , where p is the p-value for the statistical test.
Why the result needs careful reading
The SSc-ILD result is suggestive, but it is not a clinical threshold. The study reports a mean Th-cell proportion and examines its relationship with pulmonary function; it does not show that the proportion can predict future decline, tell doctors when to start a treatment, or identify a level that applies to every patient. Those questions require evidence beyond a retrospective comparison.
The size of the subgroups also limits how far the numbers can be generalized. There were 29 patients in SSc-ILD, compared with 95 in PM/DM-ILD and 58 in SS-ILD. A finding seen in a small subgroup needs testing in larger groups before it can be used to sort patients by risk. The single-center design adds another reason to treat the result as a research finding rather than a ready-made tool.
The figures should also be read on their own terms. The 1.381 × 10^9/L value is an absolute lymphocyte count, while 76.2%, 49.39% and 32.76% are proportions. A count tells how many cells were measured in a volume of blood; a proportion tells how large a share of the measured lymphocyte population belonged to a particular group. Those are different measurements and should not be treated as a single scale.
The study gives researchers a map of immune differences across CTD-ILD, healthy controls and IPF, and it keeps open a more difficult question: whether repeated Th-cell measurements will track later changes in lung function. For now, the evidence supports a distinct immune pattern in SSc-ILD, alongside lower lymphocyte counts across CTD-ILD groups, but not a causal explanation or a validated biomarker for routine care.
Paper data and sources
Original title: Connective tissue disease-associated interstitial lung disease: immune profiling and correlation of immune cells with pulmonary function in SSc-ILD
Authors: Yang Z, Li H, Qin C et al.
Journal/Repository: Annals of medicine
Status: Peer-reviewed
First online: 2026-10-19
DOI: Not available
Original paper · Full text